Alzheimer's disease: a family evaluating a cell-therapy offer

A parent or partner is losing memory and independence, approved treatment options feel limited, and a clinic proposes an infusion described as neural repair. The urgent question is not whether stem cells sound promising; it is whether the exact product and delivery route have been studied in people resembling your family member.

What the data says for this situation

The registry contains cell-therapy research for Alzheimer's disease, but a registered study can be early, incomplete or unrelated to a commercial infusion. Cell source, route, disease stage, comparator and cognitive endpoint must all match before a paper can support an offer.

Questions worth asking any provider

1. What exact cell product and route are proposed?
2. Which registered study used that same product in a comparable disease stage?
3. Which validated cognitive or functional endpoint was measured, and for how long?
4. Who manages medicines, consent capacity and follow-up at home?

Red flags specific to this situation

• A generic IV infusion described as crossing into or rebuilding the brain without product-specific evidence
• Testimonials used instead of cognitive and functional measures
• Pressure to act before an independent dementia specialist reviews the records

Cost context

Request an itemised written quote only after the product and evidence pathway are identified. Travel, carer time and long-term follow-up can exceed the headline procedure price.

FAQ

Does a registered Alzheimer's stem-cell study mean treatment is available?

No. Registration records research activity; it does not establish approval, completion or benefit.

What should a family compare first?

The exact product, route, studied population, outcome measure and follow-up — not the word stem cell alone.

→ Build questions for a specific provider · → Cost calculator

Interactive/editorial page by the StemCellAtlas research team. Where registry or literature counts appear, they use the dated 2026-08-29 snapshot. Browser-only tools do not send or store answers. Page generated 2026-08-29. See our editorial standards.